Clinical trial

Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of…

NCT00193882 · Trans Tasman Radiation Oncology Group, Other · Completed

Key facts

NCT number NCT00193882
Title Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
Official title A Randomised Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated With Radiotherapy vs ChemoRadiotherapy.
Lead sponsor Trans Tasman Radiation Oncology Group, Other
Collaborators National Health and Medical Research Council, Australia Canadian Cancer Trials Group
Status Completed
Phase Phase 3
Study type Interventional
Conditions Esophagus Cancer
Intervention type Drug, Radiation
Interventions Cisplatin, Radiotherapy, 5-Fluorouracil
Enrollment 220
Start date Jul 7, 2003
Primary completion Mar 21, 2012
Completion Jun 18, 2013
First posted Sep 19, 2005
Last update posted Jul 12, 2017
Countries Australia, Canada, New Zealand, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies